(Q33807320)

29 July 2017

1 reference

title

Pathogenicity of microbes associated with cystic fibrosis (English)

1 reference

29 July 2017

0 references

M L Hutchison

1

1 reference

PubMed ID

10617932

29 July 2017

J R Govan

series ordinal

2

1 reference

29 July 2017

1 October 1999

1 reference

29 July 2017

Microbes and Infection

1 reference

29 July 2017

1

1 reference

29 July 2017

12

1 reference

29 July 2017

1005-1014

1 reference

Microbiology of lung infection in cystic fibrosis

29 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2980518-8

7 January 2021

Cystic fibrosis epithelial cells have a receptor for pathogenic bacteria on their apical surface

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2980518-8

7 January 2021

Adherence of Staphylococcus aureus to squamous epithelium: role of fibronectin and teichoic acid.

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2980518-8

7 January 2021

Pseudomonas aeruginosa pili bind to asialoGM1 which is increased on the surface of cystic fibrosis epithelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2980518-8

7 January 2021

Staphylococcus aureus: biology, mechanisms of virulence, epidemiology

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2980518-8

7 January 2021

Evidence for a clonal origin of methicillin resistance in Staphylococcus aureus.

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2980518-8

7 January 2021

Clonal analysis of methicillin-resistant Staphylococcus aureus strains from intercontinental sources: association of the mec gene with divergent phylogenetic lineages implies dissemination by horizontal transfer and recombination

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2980518-8

7 January 2021

Comparison of enterotoxins and haemolysins produced by methicillin-resistant (MRSA) and sensitive (MSSA) Staphylococcus aureus

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2980518-8

7 January 2021

The role of environmental factors in the regulation of virulence-determinant expression in Staphylococcus aureus 8325-4

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2980518-8

7 January 2021

Different Susceptibility of Elastase Inhibitors to Inactivation by Proteinases fromStaphylococcus aureusandPseudomonas aeruginosa

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2980518-8

7 January 2021

Persistent infection with small colony variant strains of Staphylococcus aureus in patients with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2980518-8

7 January 2021

Gentamicin-resistant menadione and hemin auxotrophic Staphylococcus aureus persist within cultured endothelial cells.

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2980518-8

7 January 2021

Staphylococcus aureus stimulates neutrophil recruitment by stimulating interleukin-8 production in dog trachea.

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2980518-8

7 January 2021

Loss of ciliary activity in organ cultures of rat trachea treated with lipo-oligosaccharide from Haemophilus influenzae

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2980518-8

7 January 2021

The effects of low concentrations of antibiotics on epithelial damage caused by non-typable Haemophilus influenzae and bacterial morphology

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2980518-8

7 January 2021

Auxotrophic variants of Pseudomonas aeruginosa are selected from prototrophic wild-type strains in respiratory infections in patients with cystic fibrosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2980518-8

7 January 2021

COMPARISON OF SOME PROPERTIES OF PSEUDOMONAS AERUGINOSA ISOLATED FROM INFECTIONS IN PERSONS WITH AND WITHOUT CYSTIC FIBROSIS

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2980518-8

7 January 2021

Prevention of chronic Pseudomonas aeruginosa colonisation in cystic fibrosis by early treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2980518-8

7 January 2021

Incidence of common pyocin types of Pseudomonas aeruginosa from patients with cystic fibrosis and chronic airways diseases

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2980518-8

7 January 2021

Role of flagella in pathogenesis of Pseudomonas aeruginosa pulmonary infection

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2980518-8

7 January 2021

CFTR gene transfer reduces the binding of Pseudomonas aeruginosa to cystic fibrosis respiratory epithelium

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2980518-8

7 January 2021

Role of mutant CFTR in hypersusceptibility of cystic fibrosis patients to lung infections.

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2980518-8

7 January 2021

Human beta-defensin-1 is a salt-sensitive antibiotic in lung that is inactivated in cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2980518-8

7 January 2021

Cystic fibrosis airway epithelia fail to kill bacteria because of abnormal airway surface fluid.

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2980518-8

7 January 2021

Mouse beta defensin-1 is a functional homolog of human beta defensin-1

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2980518-8

7 January 2021

Impaired ability of Cftr knockout mice to control lung infection with Pseudomonas aeruginosa.

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2980518-8

7 January 2021

Mucin gene (MUC 2 and MUC 5AC) upregulation by Gram-positive and Gram-negative bacteria.

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2980518-8

7 January 2021

Function and activation of NF-kappa B in the immune system

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2980518-8

7 January 2021

Reduced upper airway nitric oxide in cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2980518-8

7 January 2021

Lack of inducible nitric oxide synthase in bronchial epithelium: a possible mechanism of susceptibility to infection in cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2980518-8

7 January 2021

Pseudomonas cepacia infection in cystic fibrosis: an emerging problem

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2980518-8

7 January 2021

Microbiology of airway disease in patients with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2980518-8

7 January 2021

Controlled study of Pseudomonas cepacia and Pseudomonas maltophilia in cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2980518-8

7 January 2021

Burkholderia cepacia: medical, taxonomic and ecological issues

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2980518-8

7 January 2021

A physical genome map of the Burkholderia cepacia type strain

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2980518-8

7 January 2021

The detection of insertion sequences within the human pathogen Burkholderia pseudomallei which have been identified previously in Burkholderia cepacia

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2980518-8

7 January 2021

Occurrence of multiple genomovars of Burkholderia cepacia in cystic fibrosis patients and proposal of Burkholderia multivorans sp. nov.

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2980518-8

7 January 2021

Characterization of the penA and penR genes of Burkholderia cepacia 249 which encode the chromosomal class A penicillinase and its LysR-type transcriptional regulator

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2980518-8

7 January 2021

Nucleotide sequence analysis of a gene from Burkholderia (Pseudomonas) cepacia encoding an outer membrane lipoprotein involved in multiple antibiotic resistance.

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2980518-8

7 January 2021

Identification of transposable elements which activate gene expression in Pseudomonas cepacia

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2980518-8

7 January 2021

Burkholderia cepacia produces a hemolysin that is capable of inducing apoptosis and degranulation of mammalian phagocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2980518-8

7 January 2021

Characterization of hemolytic and antifungal substance, cepalycin, from Pseudomonas cepacia.

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2980518-8

7 January 2021

The dsbB gene product is required for protease production by Burkholderia cepacia

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2980518-8

7 January 2021

Production of lipase by clinical isolates of Pseudomonas cepacia

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2980518-8

7 January 2021

Infection with Pseudomonas cepacia in chronic granulomatous disease: role of nonoxidative killing by neutrophils in host defense

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2980518-8

7 January 2021

Priming of neutrophil respiratory burst activity by lipopolysaccharide from Burkholderia cepacia.

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2980518-8

7 January 2021

Characterization of hemolysin in extracellular products of Pseudomonas cepacia

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2980518-8

7 January 2021

Cepacidine A, a novel antifungal antibiotic produced by Pseudomonas cepacia. II. Physico-chemical properties and structure elucidation

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2980518-8

7 January 2021

Cable (cbl) type II pili of cystic fibrosis-associated Burkholderia (Pseudomonas) cepacia: nucleotide sequence of the cblA major subunit pilin gene and novel morphology of the assembled appendage fibers

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2980518-8

7 January 2021

The emergence of a highly transmissible lineage of cbl+ Pseudomonas (Burkholderia) cepacia causing CF centre epidemics in North America and Britain

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2980518-8

7 January 2021

Serum IgG and sputum IgA antibody to core lipopolysaccharide antigen from Pseudomonas cepacia in patients with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2980518-8

7 January 2021

Role of anti-pseudomonal antibiotics in the emergence of Stenotrophomonas maltophilia in cystic fibrosis patients

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2980518-8

7 January 2021

Stenotrophomonas maltophilia in cystic fibrosis: incidence and prevalence

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2980518-8

7 January 2021

10.1016/S1286-4579(99)80518-8

Identifiers

DOI

1 reference

29 July 2017

1 reference

PubMed ID

10617932